With these developing tools, Dick and colleagues demonstrated that, in human acute myeloid leukemia (AML), a rare malignant cell showed the ability to repopulate the entire original disease over several transplantations and that such a cell population existed within the immature CD34+CD38−, and not the CD34+CD38+, sub-population [6]. Here, CD38 is linked to acute myeloid leukemia.